SMARCA2 and chronic myelogenous leukemia, BCR-ABL1 positive: The analysis identified six significant gene sets at the diabetes studies and the combined datasets, including “UV response”, “chronic myelogenous leukemia”, “KLF1 targets”, “SMARCA2 targets”, “Alzheimer’s disease” and “stromal stem cells”.